ASP Isotopes (NASDAQ:ASPI) Trading Down 5.3% Following Insider Selling

Shares of ASP Isotopes Inc. (NASDAQ:ASPI) traded down 5.3% on Tuesday after an insider sold shares in the company. The stock traded as low as $5.38 and last traded at $5.4050. 1,337,331 shares changed hands during trading, a decline of 70% from the average session volume of 4,482,298 shares. The stock had previously closed at $5.71.

Specifically, CFO Heather Kiessling sold 80,000 shares of the company’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $5.80, for a total value of $464,000.00. Following the sale, the chief financial officer owned 732,500 shares in the company, valued at $4,248,500. This represents a 9.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Cantor Fitzgerald initiated coverage on shares of ASP Isotopes in a report on Thursday, December 4th. They issued an “overweight” rating and a $13.00 price objective for the company. Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 target price on shares of ASP Isotopes in a research note on Monday, November 24th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday. Finally, Loop Capital set a $15.00 target price on shares of ASP Isotopes in a research note on Monday, October 27th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $13.00.

ASP Isotopes Stock Down 5.1%

The firm has a market capitalization of $600.75 million, a price-to-earnings ratio of -4.17 and a beta of 3.41. The firm has a fifty day moving average price of $7.22 and a 200 day moving average price of $8.49. The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings data on Wednesday, November 19th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.05). ASP Isotopes had a negative net margin of 1,259.12% and a negative return on equity of 190.44%. The company had revenue of $4.89 million during the quarter, compared to analyst estimates of $2.25 million. As a group, sell-side analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. FNY Investment Advisers LLC increased its position in ASP Isotopes by 1,137.6% during the third quarter. FNY Investment Advisers LLC now owns 12,500 shares of the company’s stock worth $120,000 after buying an additional 11,490 shares in the last quarter. Tudor Investment Corp ET AL grew its stake in shares of ASP Isotopes by 37.5% in the third quarter. Tudor Investment Corp ET AL now owns 460,685 shares of the company’s stock valued at $4,432,000 after buying an additional 125,687 shares in the last quarter. Penn Capital Management Company LLC increased its stake in ASP Isotopes by 983.0% during the 3rd quarter. Penn Capital Management Company LLC now owns 202,144 shares of the company’s stock worth $1,945,000 after buying an additional 183,479 shares during the period. Caitong International Asset Management Co. Ltd increased its holdings in ASP Isotopes by 331.2% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 12,622 shares of the company’s stock worth $121,000 after purchasing an additional 9,695 shares during the last quarter. Finally, Advisory Services Network LLC raised its stake in shares of ASP Isotopes by 125.8% in the 3rd quarter. Advisory Services Network LLC now owns 31,238 shares of the company’s stock valued at $301,000 after purchasing an additional 17,403 shares in the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.